Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5050)	7/31/1998 5:26:00 PM
From: Bhag Karamchandani	Read Replies (2) \| Respond to of 6136

Appreciate your comments and note your impatience when my views do not coincide with yours. That's fine as long as we maintain a degree of civility ( it is an integral part of being Canadian, I guess. Ever watch Due South?). I have previously said that I have learned a lot from your postings - it does not follow that we have to agree with on everything. How do YOU think the market will react to poor AG 3340 data? Also, I take it you don't have an opinion on Remmune PIII 'stand alone' trials. I did overlook your reference to Chiroscience. Will follow up on it. Also, anything you can point to on the next generation PI's. Thanks. Cheers.